CSL Limited (ASX: CSL)
Australia
· Delayed Price · Currency is AUD
283.39
-2.34 (-0.82%)
Nov 7, 2024, 4:10 PM AEST
CSL Limited Company Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology.
The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
CSL Limited
Country | Australia |
Founded | 1916 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 32,698 |
CEO | Paul McKenzie |
Contact Details
Address: 655 Elizabeth Street Melbourne, VIC 3000 Australia | |
Phone | 61 3 9389 1911 |
Website | csl.com.au |
Stock Details
Ticker Symbol | CSL |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | USD |
ISIN Number | AU000000CSL8 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Dr. Paul F. McKenzie Ph.D. | MD, Chief Executive Officer and Executive Director |
Joy Carolyn Linton B.Com., BComm, GAICD, Grad Dip AFI | Interim Executive Vice President of CSL Behring |
Andy Schmeltz | Executive Vice President of CSL Behring Business Unit (Leave of Absence) |
John A. G. Levy CPA | Interim Chief Financial Officer |
Chris Cooper | Head of Investor Relations |
Gregory Boss B.S., BS(Hons), J.D. | Executive Vice President of Legal and General Counsel |
Roanne Parry | Chief Human Resources Officer |
Dr. Karen Etchberger | Executive Vice President of Quality and Business Services |
Jemimah Brennan | Head of Communications - Asia Pacific |
Dr. Andrew D. Nash BSc (Hons), GAICD, Ph.D. | Senior Vice President of Research |